COLUMBUS, Ga., Sept. 18, 2019 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will webcast its annual Financial Analysts Briefing on September 25, 2019 beginning at 8:00 a.m. (ET). Aflac's management will discuss its operations in Japan and

OLDWICK, N.J., Sept. 18, 2019 /PRNewswire/ -- Provention Bio, Inc., (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering are to be sold by Provention

WEST DES MOINES, Iowa, Sept. 18, 2019 /PRNewswire/ -- Telligen has been selected to partner with the Virginia Department of Behavioral Health and Developmental Services to perform Support Intensity Scale® (SIS®) assessments in the Northern, Central and Western regions of the Commonwealth.These assessments seek to facilitate a life of possibilities for

ALEXANDRIA, La., Sept. 17, 2019 /PRNewswire/ -- Louisiana Eye and Laser, home to ophthalmologists Dr. Michael Redmond and Dr. Patrick Redmond, performed the first PanOptix Lens replacement surgeries in cataract patients in the central and northern Louisiana regions last week. This advanced procedu

HILLSBORO, Ore., Sept. 18, 2019 /PRNewswire/ -- Thermo Fisher Scientific today introduced the Thermo Scientific Phenom ParticleX, a versatile and intuitive desktop scanning electron microscope (SEM) solution that is designed to provide automotive suppliers and additive manufacturing companies faster quality control analyses of materials used in development and

NEW BRUNSWICK, N.J., Sept. 18, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 15th to review third-quarter results.  Joseph J. Wolk, Executive Vice President, Chief Financial Officer and

DUBLIN, Sept. 18, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, September 25, 2019 at 9:00 p.m. EDT/2:00 a.m. IST (September 26, 2019) to provide investors with a business update, includ

BEIJING, Sept. 18, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter, dated

ORANGE and LOS ANGELES Counties, Calif., Sept. 18, 2019 /PRNewswire/ -- MemorialCare Research Program has been awarded accreditation by the Association of Human

BIRMINGHAM, Ala., Sept. 18, 2019 /PRNewswire/ -- Therapy Brands is pleased to welcome and announce Ryan Anschuetz as the Vice President of Sales. Anschuetz